WUSTL  |  WUSM  |  SCC |  BJC |  Give a Gift
DeptName
img1 img2 img3 img4 img6 img7 img8

Chairman's Message

The Department of Radiation Oncology at the Washington University School of Medicine is dedicated to excellence in patient care, teaching and research. The department is one of the largest in the United States and a national leader in developing the most recent radiationtreatments for cancer patients. These ongoing developments provide an exciting and rich training environment for radiation oncology health care providers. The department is a component of Mallinckrodt Institute of Radiology (MIR) which provides a rich endowment and remarkable environment for research and technology development. The department consists of 4 divisions that include biology, physics and clinical divisions, plus a newly created division in bioinformatics and outcomes research. Major new equipment projects have seen the introduction of image-guided therapy as part of routine practice and the establishment of a proton treatment facility, scheduled for 2013. These new initiatives provide the patients with the latest cutting-edge technology to treat cancer.

Washington University School of Medicine is ranked among the nation's top five medical schools. The school is affiliated with Barnes-Jewish Hospital, which is listed among the nation's top 10 hospitals by U.S. News and World Report. The Alvin J. Siteman Cancer Center is a National Cancer Institute supported comprehensive cancer center, an honor given to select institutions that offer world-class comprehensive care, perform extensive cancer research, and provide active community education programs. Through affiliation with the Alvin J. Siteman Cancer Center and Barnes-Jewish Hospital, the Department of Radiation Oncology at Washington University School of Medicine is committed to its patients in all aspects of cancer care. Faculty in the Department of Radiation Oncology provide leadership in Siteman Cancer Center and contribute significantly to developmental therapeutic and clinical trials research.